Search Tag: prostate cancer

Cardiology Management

Esccongress-pronounce-trial-safety-of-adt-remains-unresolved

2021 30 Aug

Late-breaking research from the PRONOUNCE trial was presented in a Hot Line session at ESC Congress 2021. The cardiovascular safety of androgen deprivation therapy (ADT) for prostate cancer remains unresolved after the trial was terminated early.   Every year, approximately one million men are diagnosed with prostate cancer worldwide. These patients...Read more